Stay updated on Crenezumab in PSEN1 E280A Mutation Clinical Trial
Sign up to get notified when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.

Latest updates to the Crenezumab in PSEN1 E280A Mutation Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, affecting only footer links and revision metadata. These changes do not alter the Study Details content or navigation within the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a note stating that publications are automatically filled from PubMed. Updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding lapse notice regarding NIH operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedThe updates appear limited to formatting and layout adjustments on the Study Details page, with no changes to core study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedUpdated the page to v3.2.0 and added a prominent government funding/operating-status notice for the NIH Clinical Center; removed the previous v3.1.0 tag.SummaryDifference2%

- Check93 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.2%

Stay in the know with updates to Crenezumab in PSEN1 E280A Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.